Press "Enter" to skip to content

Alembic Pharma gets USFDA nod for 2 generic products

The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Teriflunomide tablets in the strengths of 7 mg and 14 mg, Alembic Pharmaceuticals said in a filing to BSE.

Original source:

Also Read:   U.S. drug developer Capricor places Duchenne drug trial on hold